Crossmark

Detection of Replication-Competent Adenoviral Particles in the Vector Vaccines Salnavac® and Gam-Covid-Vac® against the New Coronavirus Infection Covid-19

Crossref DOI link: https://doi.org/10.1134/S1990750824600717

Published Online: 2025-06-15

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kolomiytseva, D. Y.

Litvinova, N. A.

Shukurov, R. R.
License Information

Text and Data Mining valid from 2025-03-01

Version of Record valid from 2025-03-01
More Information

Article History

Received: 10 August 2024

Revised: 11 November 2024

Accepted: 25 November 2024

First Online: 15 June 2025

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

: This work does not contain any studies involving human and animal subjects.

: The authors of this work declare that they have no conflicts of interest.

Document is current

Any future updates will be listed below